TorreyPines Therapeutics to Host First Quarter 2008 Results Conference Call a... ( LA JOLLA Calif. May 12 /- TorreyP...)

TorreyPines Therapeutics to Host First Quarter 2008 Results Conference Call and Webcast

Date:5/12/2008

LA JOLLA, Calif., May 12 /PRNewswire-FirstCall/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) today announced that the company will conduct a conference call and audio webcast on Tuesday, May 13, 2008 at 11:00 a.m., Eastern Time (ET), in conjunction with the release of its financial results for the first quarter ended March 31, 2008. TorreyPines anticipates releasing its financial results at 7:30 a.m. ET on Tuesday, May 13, 2008.

To participate in this conference call, dial 719-325-4817, confirmation code 2644321 shortly before 11:00 a.m. ET. A replay of the call will be available from 2:00 p.m. ET. The replay number is 719-457-0820, confirmation code 2644321. The audio webcast can be accessed at: http://www.torreypinestherapeutics.com.

About TorreyPines Therapeutics

TorreyPines Therapeutics, Inc. is a biopharmaceutical company committed to providing patients with better alternatives to existing therapies through the research, development and commercialization of small molecule compounds. The company's goal is to develop versatile product candidates each capable of treating a number of acute and chronic diseases and disorders such as migraine, chronic pain, muscle spasticity and rigidity, xerostomia and cognitive disorders. The company is currently developing four product candidates: two ionotropic glutamate receptor antagonists and two muscarinic receptor agonists. Further information is available at http://www.torreypinestherapeutics.com.

Company Contact: Media Contact:

Craig Johnson David Schull

TorreyPi
'/>"/>

SOURCE TorreyPines Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:12/1/2009)..., , NEW YORK, Dec. 1 ...arch report is available in its catalogue: ,, ...ww.reportlinker.com/p0164494/Chromium---Global-Mar...um is primarily influenced by stainless steel, whi...markets is also important for growth of chromium m...

(Date:12/1/2009)..., , CAMBRIDGE, Mass., Dec. 1 /PRNew...c biology industry and to promote its potential, a...formation of the Synthetic Biology Industry Associ...ek. The goal of the association is to provide a fo...scuss the new industry, address its opportunities ...

(Date:12/1/2009)..., , SPRINGFIELD, Ill., Dec. 1 /PRNewswi... is proud to announce that it was recently awarded...Awards event on Nov. 13 in New York City. The CLIO...and innovation in the healthcare advertising indus... the world,s most recognized awards competitions f...

(Date:12/1/2009)... Congruent Software agree...including project accounting clients) to Synergy B... Seattle, WA (PRWEB) Decemb... today it has acquired the Microsoft Dynamics SL p...ness technology provider. The move was necessary d...

[0] Reportlinker Adds Chromium - Global Market Trends [0] Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology [0] Prairie Heart Institute of Illinois Wins Two CLIO Healthcare Awards [0] Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc.

...Pioneering medical device company Signostics annou...Food and Drug Administration (FDA) for its palm-si... (Photo: http://www.newscom.com/cgi-bin/prnh/2009...t-effective device that for the first time makes i...o use ultrasound in their clinical practice. Just ...

...otek,s Commitment to the Development of Farletuzum...nza,s Ability to Offer Specialty Development and M...Switzerland, May 19 Morphotek(R), Inc., a subsidi...za Group Ltd jointly announced today that they hav...upport the development and manufacturing of a subs...

...utic for IBD with Novel Mode of Action , , MOUNTA...ay announced that data from the company,s PROTECT-...ion in Crohn,s disease Trial) Phase II/III clinica...with moderate-to-severe Crohn,s disease will be pr...gestive Disease Week (DDW) meeting. Traficet-EN i...

Other Biology Technology:Signostics Receives FDA Clearance for World's Smallest Ultrasound Product 2 Morphotek(R), Inc and Lonza Group Ltd Enter Into Manufacturing Services Agreement 2 Morphotek(R), Inc and Lonza Group Ltd Enter Into Manufacturing Services Agreement 3 Morphotek(R), Inc and Lonza Group Ltd Enter Into Manufacturing Services Agreement 4 ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 2 ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 3 ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 4 ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 5

Signostics Receives FDA Clearance for World's Smallest Ultrasound Product Morphotek(R), Inc and Lonza Group Ltd Enter Into Manufacturing Services Agreement ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week

(Date:12/1/2009)...NNYVALE, Calif., Dec. 1 GestureTek...ase 3.0 - a turnkey, portable, plug and play inter...exhibits, entertainment and touring promotions. Ge...atents in camera-enabled gesture recognition techn...tertainment systems. ,, Guaranteed for quality,...

(Date:12/1/2009)..., winner of the 2009 Inserm Grand Prix., Every y... to paying tribute to outstanding,work performed ...talents, Inserm intends to,demonstrate the divers...iological, medical and,health research, and the c...ry out and,drive this research each day. The Inse...

(Date:12/1/2009)...sh. -- Time-lapsed video of individual breast tiss...life of a cell: a protein that cycles between two ...esearchers a more complete view of the internal si...ts that go awry in cancer and are targets of drug ...ls respond to growth factors, travels back and for...

Breaking Biology News(10 mins):GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2 Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2 Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3 ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 2 ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 3 ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 4 Expanding into New Markets with Customer Focused Solutions Orion Health Sees Strong Growth 50233 1 Expanding into New Markets with Customer Focused Solutions Orion Health Sees Strong Growth 50233 2 Expanding into New Markets with Customer Focused Solutions Orion Health Sees Strong Growth 50233 3 Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 4661 1 Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 4661 2 Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 4661 3 Mice run faster on high grade oil 9038 1 Mice run faster on high grade oil 9038 2

[0] GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits [0] Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix [0] ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus

...urprising capacity for repair, researchers report ...ished by Cell Press. The novel insight into the br...e clinical implications for the treatment of brain...rchers found that mice whose brains were severely ... in one region just after birth showed substantial...

...Vaccine 1 highlights the huge gap between current ...ndations endorsed by the European Union. Currently...s are receiving seasonal influenza vaccine in Euro...ions and mortality. , For the first time, resear...European public health officials to visualise the ...

...h over the bacterial contamination of spinach, it ...r world would be without the contribution to our f...tic acid-producing bacteria. Researchers from the ...DOE JGI) and the University of California, Davis,...e sequences of nine different lactic acid-producin...

Other Biology News:Neural stem cells lend the brain a surprising capacity for self-repair 2 First-time analysis reveals millions of Europeans left at risk from influenza 2 First-time analysis reveals millions of Europeans left at risk from influenza 3 Genomic comparison of lactic acid bacteria published 2

Neural stem cells lend the brain a surprising capacity for self-repair First-time analysis reveals millions of Europeans left at risk from influenza Genomic comparison of lactic acid bacteria published

Rabbit Anti-TAK1, phospho (Thr184 / Thr187) Monoclonal Antibody, Unconjugated, Clone 90C7 from Cell Signaling Technology

Rat Anti-Gamma delta T Lymphocytes Monoclonal Antibody, Unconjugated, Clone MAC320 from BD Biosciences Pharmingen

Rabbit Anti-Human FAK, phospho (Ser843) Antibody, Unconjugated from Upstate

Mouse Anti-DcR1 Monoclonal Antibody, Biotin Conjugated, Clone DJR3 from Abcam

Biology Products:

Rabbit Anti-TAK1, phospho (Thr184 / Thr187) Monoclonal Antibody, Unconjugated, Clone 90C7 from Cell Signaling Technology Rat Anti-Gamma delta T Lymphocytes Monoclonal Antibody, Unconjugated, Clone MAC320 from BD Biosciences Pharmingen Rabbit Anti-Human FAK, phospho (Ser843) Antibody, Unconjugated from Upstate Mouse Anti-DcR1 Monoclonal Antibody, Biotin Conjugated, Clone DJR3 from Abcam

TorreyPines Therapeutics to Host First Quarter 2008 Results Conference Call a...( LA JOLLA Calif. May 12 /- TorreyP...)